Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole

Journal of Clinical Microbiology

Volumn 43, Issue 9, 2005, Pages 4492-4497

  Austin, M N ^a   Beigi, R H ^b   Meyn, L A ^a   Hillier, S L ^a,c,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE;

ADULT; AGAR GEL DIFFUSION; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GARDNERELLA VAGINALIS; GRAM NEGATIVE BACTERIUM; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; MYCOPLASMA HOMINIS; NONHUMAN; PREVOTELLA BIVIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VAGINA FLORA; VAGINITIS;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTEROIDACEAE; BACTEROIDACEAE INFECTIONS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TREATMENT OUTCOME; VAGINA; VAGINOSIS, BACTERIAL;

BACTERIA (MICROORGANISMS); GARDNERELLA VAGINALIS; MYCOPLASMA HOMINIS; NEGIBACTERIA; PREVOTELLA; PREVOTELLA BIVIA;

EID: 24744448437     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.9.4492-4497.2005     Document Type: Article

References (30)

1. Amsel, R., P. A. Totten, C. A. Spiegel, K. C. S. Chen, D. A. Eschenbach, and K. K. Holmes. 1983. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74:14-22.
2. Aroutcheva, A., J. A. Simoes, S. Shott, and S. Faro. 2001. The inhibitory effect of clindamycin on Lactobacillus in vitro. Infect. Dis. Obstet. Gynecol. 9:239-244.
3. Behra-Miellet, J., L. Calvet, F. Mory, et al. 2003. Antibiotic resistance among anaerobic gram negative bacilli: lessons from a French multicentric survey. Anaerobe 9:105-111.
4. Beigi, R. H., M. N. Austin, L. A. Meyn, M. A. Krohn, and S. L. Hillier. 2004. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am. J. Obstet. Gynecol. 191:1124-1129.
5. Boris, J., C. Pahlson, and P. G. Larsson. 1997. Six years of observation after successful treatment of bacterial vaginosis. Infect. Dis. Obstet. Gynecol. 5:297-302.
6. Centers for Disease Control. 2002. Sexually transmitted diseases treatment guidelines. Morb. Mortal. Wkly. Rep. 51:42-48.
7. Haggoud, A., G. Reysset, H. Aseddoug, and M. Sebald. 1994. Nucleotide sequence analysis of two 5-nitroimidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of two genes. Antimicrob. Agents Chemother. 38:1047-1051.
8. Hawes, S. E., S. L. Hillier, J. Benedetti, et al. 1996. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 174:1058-1063.
9. Hillier, S. L. 1995. Treatment of bacterial vaginosis. Female Patient 5:6-16.
10. Hillier, S. L., and K. K. Holmes. 1999. Bacterial vaginosis, p. 563-586. In K. K. Holmes, P. F. Sparling, P. A. Mardh, S. M. Lemon, W. E. Stamm, P. Piot, and J. N. Wasserheit (ed.), Sexually transmitted diseases. McGraw-Hill, New York, N. Y.
11. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin. Infect. Dis. 16(Suppl. 4):S273-S281.
12. Hillier, S. L., R. P. Nugent, D. A. Eschenbach, M. A. Krohn, R. S. Gibbs, D. H. Martin, M. F. Cotch, et al. 1995. Association between bacterial vaginosis and preterm delivery of a low birth weight infant. N. Engl. J. Med. 333:1737-1742.
13. Kharsnay, A. B. M., A. A. Hoosen, and J. Van Den Ende. 1993. Antimicrobial susceptibilities of Gardnerella vaginalis. Antimicrob. Agents Chemother. 37:2733-2735.
14. Lamp, K. C., C. D. Freeman, N. E. Klutman, and M. K. Lacy. 1999. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin. Pharmacokinet. 36:353-373.
15. Larson, P. G., J. J. Platz-Christensen, H. Thejls, U. Forsum, and C. Pahlson. 1992. Incidence of pelvic inflammatory disease after first trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double blind, randomized study. Am. J. Obstet. Gynecol. 166:100-103.
16. Lee-Jene, T., H. Po-Ren, T. Jui-Chang, et al. 2002. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob. Agents Chemother. 46:2908-2913.
17. Manning, S. D., M. D. Pearlman, P. Tallman, C. L. Pierson, and B. Foxman. 2001. Frequency of antibiotic resistance among group B Streptococcus isolated from healthy college students. Clin. Infect. Dis. 33:137-139.
18. Martin, H. L., B. A. Richardson, P. M. Nyange, et al. 1999. Vaginal lactobacilli, microbial flora and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180:1950-1956.
19. Moncla, B. J., P. Braham, L. K. Rabe, and S. L. Hillier. 1991. Rapid presumptive identification of black-pigmented gram negative anaerobic bacteria by using 4-methylumbelliferone derivatives. J. Clin. Microbiol. 29:1955-1958.
20. Morales, W. J., S. S. Dickey, P. Bornick, and D. V. Lim. 1999. Change in antibiotic resistance of group B Streptococcus: impact on intrapartum management. Am. J. Obstet Gynecol. 181:310-314.
21. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard, 5th ed. NCCLS document M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. Nugent, R. P., M. A. Krohn, and S. L. Hillier. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J. Clin. Microbiol. 29:297-301.
23. Ohm-Smith, M. J., R. L. Sweet, and W. K. Hadley. 1986. Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy. Antimicrob. Agents Chemother. 30:11-14.
24. Rabe, L. K., and S. L. Hillier. 2003. Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. J. Clin. Microbiol. 41:3260-3264.
25. Rabe, L. K., D. Sheiness, and S. L. Hillier. 1995. Comparison of the use of oligonucleotide probes, 4-methylumbelliferyl derivatives, and conventional methods for identifying Prevotella bivia. Clin. Infect. Dis. 20(Suppl. 2):S195-S197.
26. Raether, W., and H. Hanel. 2003. Nitroheterocyclic drugs with broad spectrum activity. Parasitol. Res. 90:S19-S39.
27. Rasmussen, B. A., K. Bush, and F. P. Tally. 1997. Antimicrobial resistance in anaerobes. Clin. Infect. Dis. 24(Suppl. 1):S110-S120.
28. Shanker, S., M. Toohey, and R. Munro. 1982. In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis. Eur. J. Clin. Microbiol. 1:298-300.
29. Sobel, J. D., C. Schmitt, and C. Meriweather. 1993. Long term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. J. Infect. Dis. 167:783-784.
30. Watts, D. H., M. A. Krohn, S. L. Hillier, and D. A. Eschenbach. 1990. Bacterial vaginosis as a risk factor for postcesarean endometritis. Obstet. Gynecol. 75:52.